2298 Federal Register / Vol. 77, No. 10 / Tuesday, January 17, 2012 / Notices 

the two groups. The video simulation 

will be approximately four-hour long 

total. All students will take a pre-test 

quiz when they fill out the 

demographics form. Once the treatment 

is completed, all students will be asked 

to take a post-test quiz and answer a 

post-viewing questionnaire to capture 

their perceptions of the video 

simulation. 

To answer the second question, the 

study will collect qualitative data from 

semi-structured interviews as well as 

focus groups. The semi-structured 

interviews will be conducted twice with 

faculty who teach the courses in the first 

part of the study, in person or on the 

phone, before and after he/she uses the 

video simulation. Participants for the 

focus groups will be selected from the 

students who participate in the first part 

of the study. The focus group will last 

one hour. 

ESTIMATED ANNUALIZED BURDEN TABLE

Forms Type of respondent Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden 

(in hours) 

per response 

Total 

burden 

hours 

Educational Interactive Video ........... Individuals/Households .................... 3000 1 14/60 700 

Keith A. Tucker, 

Office of the Secretary, Paperwork Reduction 

Act Reports Clearance Officer. 

[FR Doc. 2012–632 Filed 1–13–12; 8:45 am] 

BILLING CODE 4150–05–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Public Meeting of the Presidential 

Commission for the Study of 

Bioethical Issues 

AGENCY: Office of the Assistant 

Secretary for Health, Presidential 

Commission for the Study of Bioethical 

Issues, Department of Health and 

Human Services. 

ACTION: Notice of meeting. 

SUMMARY: The Presidential Commission 

for the Study of Bioethical Issues will 

conduct its eighth meeting in February. 

At this meeting, the Commission will 

discuss issues of privacy and access 

related to human genome sequence data. 

The Commission will also be discussing 

neuroscience and related ethical issues. 

DATES: The meeting will take place 

February 2, 2012 from 9 a.m. to 

approximately 5:15 p.m. and on 

February 3, 2012 from 9 a.m. to 

approximately 12 p.m. 

ADDRESSES: Millberry Union, University 

of California, San Francisco, 500 

Parnassus Avenue, San Francisco, CA 

94143, (415) 476–2019. 

FOR FURTHER INFORMATION CONTACT: 

Hillary Wicai Viers, Communications 

Director, Presidential Commission for 

the Study of Bioethical Issues, 1425 

New York Avenue NW., Suite C–100, 

Washington, DC 20005. Telephone: 

(202) 233–3960. Email: Hillary.Viers@

bioethics.gov. Additional information 

may be obtained at http://

www.bioethics.gov. 

SUPPLEMENTARY INFORMATION: Pursuant 

to the Federal Advisory Committee Act 

of 1972, Public Law 92–463, 5 U.S.C. 

app. 2, notice is hereby given of the 

eighth meeting of the Presidential 

Commission for the Study of Bioethical 

Issues (the Commission). The meeting 

will be held from 9 a.m. to 

approximately 5:15 p.m. on Thursday, 

February 2, 2012, and from 9 a.m. to 

approximately 12 p.m. on Friday, 

February 3, 2012, in San Francisco, 

California. The meeting will be open to 

the public with attendance limited to 

space available. The meeting will also 

be webcast at http://www.bioethics.gov. 

Under authority of Executive Order 

13521, dated November 24, 2009, the 

President established the Commission. 

The Commission is an advisory panel of 

the nation’s leaders in medicine, 

science, ethics, religion, law, and 

engineering. The Commission advises 

the President on bioethical issues 

arising from advances in biomedicine 

and related areas of science and 

technology. The Commission seeks to 

identify and promote policies and 

practices that ensure scientific research, 

health care delivery, and technological 

innovation are conducted in a socially 

and ethically responsible manner. The 

main agenda item for the Commission’s 

eighth meeting is to discuss issues of 

privacy and access related to human 

genome sequence data. The Commission 

will also be discussing neuroscience 

and related ethical issues. The draft 

meeting agenda and other information 

about PCSBI, including information 

about access to the webcast, will be 

available at http://www.bioethics.gov. 

The Commission welcomes input from 

anyone wishing to provide public 

comment on any issue before it. 

Respectful debate of opposing views 

and active participation by citizens in 

public exchange of ideas can enhance 

decisions that are reached and the 

overall public understanding of them. 

The Commission is particularly 

interested in receiving comments and 

questions during the meeting that are 

responsive to specific sessions. Written 

comments will be accepted at the 

registration desk and comment forms 

will be provided for members of the 

public to write down questions and 

comments for the Commission as they 

arise. To accommodate as many 

individuals as possible, the time for 

each question or comment may be 

limited. If the number of individuals 

wishing to pose a question or make a 

comment is greater than can reasonably 

be accommodated during the scheduled 

meeting, the Commission may make a 

random selection. Anyone planning to 

attend the meeting who needs special 

assistance, such as sign language 

interpretation or other reasonable 

accommodations, should notify Esther 

Yoo by telephone at (202) 233–3960, or 

email at Esther.Yoo@bioethics.gov in 

advance of the meeting. The 

Commission will make every effort to 

accommodate persons who need special 

assistance. Written comments will also 

be accepted in advance of the meeting 

and are especially welcome. Please 

address written comments by email to 

info@bioethics.gov, or by mail to the 

following address: Public Commentary, 

Presidential Commission for the Study 

of Bioethical Issues, 1425 New York 

Ave. NW., Suite C–100, Washington, DC 

20005. Comments will be publicly 

available, including any personally 

identifiable or confidential business 

information that they contain. Trade 

secrets should not be submitted. 

Dated: January 6, 2012. 

Valerie H. Bonham, 

Executive Director, Presidential Commission 

for the Study of Bioethical Issues. 

[FR Doc. 2012–650 Filed 1–13–12; 8:45 am] 

BILLING CODE 4154–06–P 


srobinson on DSK4SPTVN1PROD with NOTICES